中药复方硬肝复康治疗乙型肝炎和肝硬化临床疗效  

A Primary Summary of the Effects of Yingganfukang in Treating B-type Virus Hepatitis and Hepatocirrhosis

作　　者：王天然[1] 曾祥元[1] 马布仁[1] 

机构地区：[1]成都军区总医院中心实验室,成都610083

出　　处：《西南军医》2006年第1期14-16,共3页Journal of Military Surgeon in Southwest China

摘　　要：目的研究硬肝复康临床治疗肝炎和肝硬化的效果。方法将四川省部分市、地、县及军队医院临床应用硬肝复康的资料进行小结和分析。结果应用硬肝复康治疗乙型病毒性肝炎44例,总有效率93.2%,明显高于甘草甜素对照组的85.0%(P<0.05);且硬肝复康组HBV标志改善率、化验指标和临床症状改善率均明显高于对照组(P<0.05)。多家医院临床应用硬肝复康治疗各种肝硬化共459例,总有效率92.4%;治疗三月后,大多患者临床症状和体征、化验指标等显著改善。结论硬肝复康对乙型肝炎和各种肝硬化具有显著临床疗效。Objective To study the clinical effects of a traditional Chinese medicine compound, Yingganfukang （GFK）,in treating B-type virus hepatitis and hepatocirrhosis. Methods The information from several hospitals in Sichuan Province, using GFK clinically, was analyzed and primarily summarized. Results （1）GFK had been used to treat 44 cases with B-type virus hepatitis, and the total efficiency reached 93.2 %, which was much higher than that of the control group, 85.0 %. The improvements of HBV marks,some indexes of clinical tests and clinical symptoms in GFK treated group were more remarkable than those in control group （ P 〈 0.05 ） .（2）459 patients with various types of hepatocirrhosis had been treated with GFK in several hospitals,and the total efficiency reached 92.4 %. After 3 months of treatment with GFK, the clinical symptoms and evidences, clinical test indexes of the patients were significantly improved. Conclusions GFK is of well clinical effects in treating patients with B-type virus hepatitis and various hepatocirrhosis.

关 键 词：硬肝复康 肝炎 肝硬化 临床治疗 

分 类 号：R512.6[医药卫生—内科学]